Colocalization of BAX with BID and VDAC-1 in nimesulide-induced apoptosis of human colon adenocarcinoma COLO 205 cells

Anti-Cancer Drugs

Volumn 13, Issue 10, 2002, Pages 1017-1029

  Godlewski, Michat Marek ^a   Gajkowska, Barbara ^b   Lamparska Przybysz, Monika ^a   Motyl, Tomasz ^a  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Apoptosis; BAX; BID; COLO 205; Nimesulide; Prostaglandin E2; VDAC 1

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; PROTEIN BAX; PROTEIN BID; VOLTAGE GATED CHANNEL FORMING PROTEIN;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL ORGANELLE; CELL SURVIVAL; CELLULAR DISTRIBUTION; COLON ADENOCARCINOMA; CONTROLLED STUDY; CYTOMETRY; DRUG EFFECT; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; IMMUNOELECTRON MICROSCOPY; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; BLOTTING, WESTERN; CARRIER PROTEINS; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; HUMANS; INTRACELLULAR MEMBRANES; ISOENZYMES; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; MICROSCOPY, IMMUNOELECTRON; PORINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SULFONAMIDES; TUMOR CELLS, CULTURED; VOLTAGE-DEPENDENT ANION CHANNEL 1; VOLTAGE-DEPENDENT ANION CHANNELS;

EID: 12244283693     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200211000-00006     Document Type: Article

References (45)

1. Boersma AWM, Nooter K, Burger H, Kortland CJ, Stoter G. Bax upregulation is an early event in cisplatin-induced apoptosis in human testicular germ-cell tumor cell line NT2, as quantitated by flow cytometry. Cytometry 1997; 27: 275-82.
2. Schmitt E, Steyaert A, Cimoli G, Bertrand R. Bax-α promotes apoptosis induced by cancer chemotherapy and accelerates the activation of caspase 3-like cysteine proteases in p53 double mutant B lymphoma namalwa cells. Cell Death Different 1998; 5: 503-16.
3. Kobayashi T, Sawa H, Morikawa J, Zhang W, Shiku H. Bax induction activates apoptotic cascade via mitochondrial cytochrome c release and Bax overexpression enhances apoptosis induced by chemotherapeutic agents in DLD-1 colon cancer cells. Jpn J Cancer Res 2000; 91: 1264-8.
4. Nio Y, Iguchi C, Yamasawa K, et al. Apoptosis and expression of Bcl-2 and Bax proteins in invasive ductal carcinoma of the pancreas. Pancreas 2001; 22: 230-9.
5. Godlewski MM, Motyl MA, Gajkowska B, Warȩski P, Koronkiewicz M, Motyl T. Subcellular redistribution of BAX during apoptosis induced by anticancer drugs. Anti-Cancer Drugs 2001; 12: 607-17.
6. Rampino N, Yamamoto H, Ionov Y, et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997; 275: 967-9.
7. Yagi OK, Akiyama Y, Nomizu T, Iwama T, Endo M, Yuasa Y. Proapoptotic gene BAX is frequently mutated in hereditary nonpolyposis colorectal cancers but not in adenomas. Gastroenterology 1998; 114: 268-74.
8. Tsujimoto Y, Shimizu S. Bcl-2 family: Life-or-death switch. FEBS Lett 2000; 466: 6-10.
9. Tsujimoto Y, Shimizu S. VDAC regulation by the Bcl-2 family of proteins. Cell Death Different 2000; 7: 1174-81.
10. Shimizu S, Ide T, Yanagida T, Tsujimoto Y. Electrophysiological study of novel large pore formed by bax and the voltage-dependent anion channel that is permeable to cytochrome c. J Biol Chem 2000; 275: 12321-5.
11. Daugas E, Susin SA, Zamzami N, et al. Mitochondria-nuclear translocation of AIF in apoptosis and necrosis. FASB J 2000; 14: 729-39.
12. Wolter KG, Hsu Y-T, Smith CL, Nechushtan A, Xi X-G, Youle RJ. Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol 1997; 139: 1281-92.
13. 1-induced programmed cell death of HC11 mouse mammary epithelial cells. Cell Mol Biol 2000; 46: 175-85.
14. Mandal M, Adam L, Mendelsohn J, Kumar R. Nuclear targeting of Bax during apoptosis in human colorectal cancer cells. Oncogene 1998; 17: 999-1007.
15. Gajkowska B, Motyl T, Olszewska-Ba̧darczuk H, Godlewski MM. Expression of BAX in cell nucleus after experimentally induced apoptosis revealed by immunogold and embedment free-electron microscopy. Cell Biol Int 2001; 25: 725-33.
16. Gao G, Dou P. N-Terminal cleavage of Bax by calpain generates a potent proapoptotic 18-kDa fragment that promotes Bcl-2-independent cytochrome c release and apoptotic cell death. J Cell Biochem 2000; 80: 53-72.
17. Eskes R, Desagher S, Antonsson B, Martinou JC. Bid induces the oligomerization and insertion of Bax into outer mitochondrial membrane. Mol Cell Biol 2000; 20: 929-35.
18. Cuddeback SM, Yamaguchi H, Komatsu K, et al. Molecular cloning and characterization of Bif-1: A novel Src homology 3 domain-containing protein that associates with Bax. J Biol Chem 2001; 276: 20559-65.
19. Conus S, Kaufman T, Fellay I, Otter I, Rosse T, Borner C. Bcl-2 is a monomeric protein: Prevention of homodimerization by structural constraints. EMBO J 2000; 19: 1534-44.
20. Antonsson B, Montessuit S, Lauper S, Eskes R, Martinou J-C. Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release form mitochondria. Biochem J 2000; 345: 271-8.
21. Mikhailov V, Mikhailova M, Pulkrabek DJ, Dong Z, Venkatachalam MA, Saikumar P. Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane. J Biol Chem 2001; 276: 18361-74.
22. Desagher S, Osen-Sand A, Nichols A, et al. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Biol Chem 1999; 144: 891-901.
23. McDonnell JM, Fushman D, Milliman CL, Korsmeyer SJ, Cowburn D. Solution structure of the proapoptotic molecule BID: A structural basis for apoptotic agonists and antagonists. Cell 1999; 96: 625-34.
24. Xu X-C. COX-2 inhibitors in cancer treatment and prevention, a recent development. Anti-Cancer Drugs 2002; 13: 127-37.
25. Fukutake M, Nakatsugi S, Isoi T, et al. Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carinogenesis in mice. Carcinogenesis 1998; 19: 1939-42.
26. Hida T, Kozaki K, Muramatsu H, et al. Cyclo-oxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer lines. Clin Cancer Res 2000; 6: 2006-11.
27. Zhang Z, Dubois RN. Par-4, a proapoptotic gene, is regulated by NSAIDs in human colo carcinoma cells. Gastroenterology 2000; 118: 1012-7.
28. Tardieu D, Jaeg JP, Deloly A, Corpet DE, Cadet J, Petit CR. The COX-2 inhibitor nimesulide suppresses superoxide and 8-hydroxy-deoxyguanosine formation, and stimulates apoptosis in mucosa during early colonic inflammation in rats. Carcinogenesis 2000; 21: 973-6.
29. Nakatsugi S, Fukutake M, Takahashi M, et al. Suppression of intestinal polyp development by Nimesulide, a selective cyclooxygenase-2 inhibitor, in min mice. Jpn J Cancer Res 1997; 88: 1117-20.
30. Taniguchi Y, Ikesue A, Yokoyama K, et al. Selective inhibition by nimesulide, a novel non-steroidal anti-inflammatory drug, with prostaglandin endoperoxide synthase-2 activity in-vitro. Pharm Sci 1995; 1: 173-5.
31. Hsu AL, Ching TT, Wang DS, Song X, Rangnekar VM, Chen CS. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J Biol Chem 2000; 275: 11397-403.
32. Tsuji M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995; 83: 493-501.
33. Ding HF, Lin YL, McGill G, et al. Essential role for caspase-8 in transcription-independent apoptosis triggered by p53. J Biol Chem 2000; 275: 38905-11.
34. Liu XH, Kirschenbaum A, Yao S, Lee R, Holland JF, Levine AC. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer. In Vivo. J Urol 2000; 164: 820-5.
35. Liu CH, Chang SH, Narko K, et al. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem 2001; 276: 18563-9.
36. Zimmermann KC, Waterhouse NJ, Goldstein JC, Schuler M, Green DR. Aspirin induces apoptosis through release of cytochrome c from mitochondria. Neoplasia 2000; 2: 505-13.
37. Chan TA, Morin PJ, Vogelstein B, Kinzler KW. Mechanisms underlying nonsteroidal anti-inflammatory drug-mediated apoptosis. Proc Natl Acad Sci USA 1998; 95: 681-6.
38. 2 in human colon cancer cells. Cancer Res 1998; 58: 363-6.
39. Liu XH, Yao S, Kirschenbaum A, Levine AC. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res 1998; 58: 4245-9.
40. Baek SJ, Kim KS, Nixon JB, Wilson LC, Eling TE. Cyclooxygenase inhibitors regulate the expression of TGF-β superfamily member that has proapoptotic and antitumorigenic activities. Mol Pharmacol 2001; 59: 901-8.
41. Zimowska W, Motyl T, Skierski J, et al. Apoptosis and Bcl-2 protein changes in L1210 leukaemic cells exposed to oxidative stress. Apoptosis 1997; 2: 529-39.
42. Zimowska W, Motyl T, Warȩski P, Skierski J, Płoszaj T, Orzechowski A. Apoptosis induced by serum deprivation and apoptogenic factors of cellular origin is dependent on bcl-2 and bax expression in L1210 leukaemic cells. Polish J Vet Sci 2000; 3: 63-71.
43. Kudla G, Montessuit S, Eskes R, et al. The destabilization of lipid membranes induced by the C-terminal fragment of caspase-8-cleaved Bid is inhibited by the N-terminal fragment. J Biol Chem 2000; 275: 22713-8.
44. Polster BM, Kinnaly KW, Fiskum G. BH3 death domain peptide induces cell-type selective mitochondrial outer membrane permeability. J Biol Chem 2001; 276: 37887-94.
45. Kim TH, Zhao Y, Barber MJ, Kuharsky DK, Yin XM. Bid-induced cytochrome c release is mediated by a pathway independent of mitochondrial permeability transition pore and Bax. J Biol Chem 2000; 275: 39474-81.